FR09C0030I2 - Composes thrombopoietiques - Google Patents

Composes thrombopoietiques

Info

Publication number: FR09C0030I2
Authority: FR; France
Prior art keywords: thrombopoietic compounds; thrombopoietic; compounds
Prior art date: 1998-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR09C0030C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amgen K A Inc

Original Assignee

Kirin Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-23

Filing date

2009-07-30

Publication date

2010-12-31

2009-07-30 Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc

2009-09-25 Publication of FR09C0030I1 publication Critical patent/FR09C0030I1/fr

2010-12-31 Application granted granted Critical

2010-12-31 Publication of FR09C0030I2 publication Critical patent/FR09C0030I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FR09C0030C 1998-10-23 2009-07-30 Composes thrombopoietiques Active FR09C0030I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10534898P	1998-10-23	1998-10-23
EP19990970998 EP1124961B9 (en)	1998-10-23	1999-10-22	Thrombopoietic compounds

Publications (2)

Publication Number	Publication Date
FR09C0030I1 FR09C0030I1 (fr)	2009-09-25
FR09C0030I2 true FR09C0030I2 (fr)	2010-12-31

Family

ID=22305310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR09C0030C Active FR09C0030I2 (fr)	1998-10-23	2009-07-30	Composes thrombopoietiques

Country Status (36)

Country	Link
US (8)	US6835809B1 (pt)
EP (3)	EP1124961B9 (pt)
JP (2)	JP3820105B2 (pt)
KR (1)	KR100719202B1 (pt)
CN (2)	CN1810832B (pt)
AR (1)	AR020934A1 (pt)
AT (1)	ATE348163T1 (pt)
AU (1)	AU773891C (pt)
BG (3)	BG110221A (pt)
BR (1)	BRPI9914698B8 (pt)
CA (1)	CA2346996C (pt)
CY (4)	CY1107526T1 (pt)
CZ (1)	CZ302155B6 (pt)
DE (2)	DE122009000039I1 (pt)
DK (3)	DK2319928T3 (pt)
EA (1)	EA003998B1 (pt)
ES (3)	ES2279649T3 (pt)
FR (1)	FR09C0030I2 (pt)
HK (2)	HK1042114B (pt)
HU (1)	HU228582B1 (pt)
IL (1)	IL142023A0 (pt)
LT (1)	LTC1124961I2 (pt)
LU (1)	LU91598I2 (pt)
ME (2)	ME00238B (pt)
MY (1)	MY126795A (pt)
NL (1)	NL300398I2 (pt)
NO (2)	NO331027B1 (pt)
NZ (1)	NZ510529A (pt)
PL (1)	PL219605B1 (pt)
PT (3)	PT1124961E (pt)
RS (1)	RS51237B (pt)
SI (3)	SI1124961T1 (pt)
SK (1)	SK287737B6 (pt)
TW (2)	TWI257394B (pt)
WO (1)	WO2000024770A2 (pt)
ZA (1)	ZA200102102B (pt)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7091311B2 (en) *	1996-06-07	2006-08-15	Smithkline Beecham Corporation	Peptides and compounds that bind to a receptor
BRPI9914698B8 (pt) *	1998-10-23	2021-05-25	Amgen Inc	composto que se liga a um receptor mp1, e , composição farmacêutica.
US6808902B1 (en) *	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
WO2001081377A2 (en) *	2000-04-21	2001-11-01	Amgen, Inc.	Integrin/adhesion antagonists
US20020090646A1 (en) *	2000-05-03	2002-07-11	Amgen Inc.	Calcitonin-related molecules
ES2228903T3 (es) *	2000-06-09	2005-04-16	The Government Of The United States America, As Represented By Departm. Of Health And Human Services	Pegilacion de ligandos que mejora la actividad antitumoral y reduce la toxicidad de inmunoconjugados.
ATE544785T1 (de)	2000-12-05	2012-02-15	Alexion Pharma Inc	Rationell entworfene antikörper
US7396917B2 (en) *	2000-12-05	2008-07-08	Alexion Pharmaceuticals, Inc.	Rationally designed antibodies
US20040018203A1 (en) *	2001-06-08	2004-01-29	Ira Pastan	Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
US20040242479A1 (en)	2001-08-17	2004-12-02	Elisabeth Bock	Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
US7332474B2 (en) *	2001-10-11	2008-02-19	Amgen Inc.	Peptides and related compounds having thrombopoietic activity
US20030191056A1 (en)	2002-04-04	2003-10-09	Kenneth Walker	Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
EP2319528B8 (en) *	2002-09-18	2020-03-04	Janssen Pharmaceuticals, Inc.	Methods of increasing platelet and hematopoietic stem cell production
TWI353991B (en)	2003-05-06	2011-12-11	Syntonix Pharmaceuticals Inc	Immunoglobulin chimeric monomer-dimer hybrids
PL1625156T3 (pl)	2003-05-12	2013-03-29	Affymax Inc	Peptydy wiążące się do receptora erytropoetyny
SG160224A1 (en)	2003-05-12	2010-04-29	Affymax Inc	Novel peptides that bind to the erythropoietin receptor
CA2525399A1 (en) *	2003-05-12	2004-11-25	Affymax, Inc.	Novel spacer moiety for poly(ethylene glycol)-modified peptide-based co mpounds
AU2004238869B2 (en) *	2003-05-12	2009-06-25	Affymax, Inc.	Novel poly(ethylene glycol) modified compounds and uses thereof
MXPA06015234A (es) *	2004-06-30	2007-11-22	Nektar Therapeutics Al Corp	Conjugados de fraccion polimero-factor ix.
WO2006010057A2 (en) *	2004-07-08	2006-01-26	Amgen Inc.	Therapeutic peptides
US7550433B2 (en)	2005-06-03	2009-06-23	Affymax, Inc.	Erythropoietin receptor peptide formulations and uses
WO2006136450A2 (en) *	2005-06-23	2006-12-28	Aplagen Gmbh	Supravalent compounds
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
WO2007075899A2 (en) *	2005-12-21	2007-07-05	Maxygen, Inc.	Dual agonist compounds and uses thereof
US9012605B2 (en)	2006-01-23	2015-04-21	Amgen Inc.	Crystalline polypeptides
AU2007208226A1 (en) *	2006-01-25	2007-08-02	Amgen Inc.	Thrombopoietic compounds
JO3324B1 (ar)	2006-04-21	2019-03-13	Amgen Inc	مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
US7981425B2 (en)	2006-06-19	2011-07-19	Amgen Inc.	Thrombopoietic compounds
CA2658639C (en)	2006-07-24	2015-08-04	The University Of Queensland	Method of producing a population of cells of the neutrophil lineage
WO2008095004A2 (en)	2007-01-31	2008-08-07	Affymax, Inc.	Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
JP5591691B2 (ja)	2007-05-22	2014-09-17	アムジエン・インコーポレーテツド	生物活性を有する融合タンパク質を作製するための組成物及び方法
WO2008157824A2 (en) *	2007-06-21	2008-12-24	Conjuchem Biotechnologies Inc.	Thrombopoietin peptide conjugates
US20110097318A1 (en) *	2007-08-31	2011-04-28	Amgen Inc.	Solid-State Protein Formulation
AU2008304111B2 (en)	2007-09-27	2014-04-24	Amgen Inc.	Pharmaceutical formulations
WO2009064838A1 (en)	2007-11-15	2009-05-22	Amgen, Inc.	Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
EP2225272B1 (en)	2007-11-28	2015-10-21	Enkam Pharmaceuticals A/S	Peptides derived from ncam (fgls)
MX2011009798A (es)	2009-03-20	2011-12-08	Amgen Inc	Inmunoglobulinas portadoras y usos de las mismas.
CA2756244A1 (en)	2009-04-02	2010-10-07	Roche Glycart Ag	Multispecific antibodies comprising full length antibodies and single chain fab fragments
RU2015153109A (ru)	2009-09-16	2019-01-15	Дженентек, Инк.	Содержащие суперспираль и/или привязку белковые комплексы и их применения
WO2011047188A1 (en) *	2009-10-16	2011-04-21	Amgen Inc.	Thrombopoietic compounds
EP2490957B1 (en)	2009-10-23	2016-11-23	Amgen, Inc	Vial adapter and system
WO2011098095A1 (en)	2010-02-09	2011-08-18	Aplagen Gmbh	Peptides binding the tpo receptor
TW201138821A (en)	2010-03-26	2011-11-16	Roche Glycart Ag	Bispecific antibodies
CA2796633C (en)	2010-04-23	2020-10-27	Genentech, Inc.	Production of heteromultimeric proteins
CA2800919C (en)	2010-06-07	2019-01-15	Amgen Inc.	Drug delivery device
CN103154032A (zh)	2010-08-13	2013-06-12	弗·哈夫曼-拉罗切有限公司	用于疾病治疗的针对IL-1β和IL-18的抗体
JP5758004B2 (ja)	2010-08-24	2015-08-05	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	ジスルフィドによって安定化されたＦｖ断片を含む二重特異性抗体
US8993727B2 (en)	2010-09-22	2015-03-31	Amgen Inc.	Carrier immunoglobulins and uses thereof
SG191153A1 (en)	2010-12-23	2013-07-31	Hoffmann La Roche	Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
JP6161540B2 (ja)	2011-02-04	2017-07-12	ジェネンテック，インコーポレイテッド	Ｆｃ変異体及びそれらの生産方法
US10689447B2 (en)	2011-02-04	2020-06-23	Genentech, Inc.	Fc variants and methods for their production
WO2012135315A1 (en)	2011-03-31	2012-10-04	Amgen Inc.	Vial adapter and system
EP4074355A1 (en)	2011-04-20	2022-10-19	Amgen Inc.	Autoinjector apparatus
CN104093744A (zh)	2011-10-11	2014-10-08	弗·哈夫曼-拉罗切有限公司	双特异性抗体的改进的组装
KR102084171B1 (ko)	2011-10-14	2020-04-14	암젠 인크	주사기 및 어셈블리 방법
MX2014009565A (es)	2012-02-10	2014-11-10	Genentech Inc	Anticuerpos monocatenarios y otros heteromultimeros.
CN102552184A (zh) *	2012-02-16	2012-07-11	山东泉港药业有限公司	一种血小板生成素拟肽冻干制剂
JP6203838B2 (ja)	2012-06-27	2017-09-27	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	少なくとも２つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
MX2014014804A (es)	2012-06-27	2015-02-12	Hoffmann La Roche	Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo.
EP3081249B1 (en)	2012-11-21	2020-12-30	Amgen Inc.	Drug delivery device
CN104046642B (zh) *	2013-03-15	2018-07-06	兰州大学	发酵生产二聚体化融合蛋白的方法
CA2904725C (en)	2013-03-15	2022-04-12	Amgen Inc.	Drug cassette, autoinjector, and autoinjector system
CN104045715B (zh) *	2013-03-15	2018-05-01	兰州大学	二聚体化融合蛋白的制备及应用
TWI614041B (zh)	2013-03-15	2018-02-11	安美基公司	用於注射器之匣盒
AU2014228177B2 (en)	2013-03-15	2018-04-26	Amgen Inc.	Body contour adaptable autoinjector device
BR112015024282B1 (pt)	2013-03-22	2022-05-17	Amgen Inc	Injetor e método de montagem do injetor
EP3421066B1 (en)	2013-10-24	2021-03-03	Amgen Inc.	Injector and method of assembly
CA2926110C (en)	2013-10-24	2023-05-23	Amgen Inc.	Drug delivery system with temperature-sensitive control
WO2015119906A1 (en)	2014-02-05	2015-08-13	Amgen Inc.	Drug delivery system with electromagnetic field generator
CN105017408B (zh) *	2014-04-30	2019-11-05	重庆派金生物科技有限公司	聚乙二醇化血小板生成素模拟肽同源四聚体及其用途
KR102603417B1 (ko)	2014-05-06	2023-11-20	제넨테크, 인크.	포유동물 세포를 사용한 이종다량체 단백질의 생산
MX2016014561A (es)	2014-05-07	2017-06-21	Amgen Inc	Autoinyetor con elementos reductores del shock.
US20170098058A1 (en)	2014-06-03	2017-04-06	Amgen Inc.	Systems and methods for remotely processing data collected by a drug delivery device
US10112977B2 (en)	2014-06-23	2018-10-30	Toagosei Co., Ltd.	Peptide for inducing multinucleation in cells, and use therefor
CA2962486A1 (en) *	2014-09-26	2016-03-31	Bayer Pharma Aktiengesellschaft	Stabilized adrenomedullin derivatives and use thereof
CA2957960C (en)	2014-10-14	2023-08-22	Amgen, Inc.	Drug injection device with visual and audible indicators
PL3227332T3 (pl)	2014-12-03	2020-06-15	F. Hoffmann-La Roche Ag	Wielospecyficzne przeciwciała
ES2785311T3 (es)	2014-12-19	2020-10-06	Amgen Inc	Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
EP3848072A1 (en)	2014-12-19	2021-07-14	Amgen Inc.	Drug delivery device with proximity sensor
WO2016129656A1 (ja) *	2015-02-12	2016-08-18	国立大学法人岩手大学	哺乳動物細胞に対する外来遺伝子の導入効率の向上剤
CA2976935C (en)	2015-02-17	2020-03-10	Amgen Inc.	Drug delivery device with vacuum assisted securement and/or feedback
EP3981450A1 (en)	2015-02-27	2022-04-13	Amgen, Inc	Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
WO2017039786A1 (en)	2015-09-02	2017-03-09	Amgen Inc.	Syringe assembly adapter for a syringe
ES2755717T3 (es)	2015-12-09	2020-04-23	Amgen Inc	Autoinyector con tapa de señalización
WO2017120178A1 (en)	2016-01-06	2017-07-13	Amgen Inc.	Auto-injector with signaling electronics
DK3429663T3 (da)	2016-03-15	2020-09-28	Amgen Inc	Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
WO2017189089A1 (en)	2016-04-29	2017-11-02	Amgen Inc.	Drug delivery device with messaging label
US11389588B2 (en)	2016-05-02	2022-07-19	Amgen Inc.	Syringe adapter and guide for filling an on-body injector
AU2017263558B2 (en)	2016-05-13	2022-12-22	Amgen Inc.	Vial sleeve assembly
EP3458988B1 (en)	2016-05-16	2023-10-18	Amgen Inc.	Data encryption in medical devices with limited computational capability
US11541176B2 (en)	2016-06-03	2023-01-03	Amgen Inc.	Impact testing apparatuses and methods for drug delivery devices
EP3478342A1 (en)	2016-07-01	2019-05-08	Amgen Inc.	Drug delivery device having minimized risk of component fracture upon impact events
WO2018034784A1 (en)	2016-08-17	2018-02-22	Amgen Inc.	Drug delivery device with placement detection
US20200261643A1 (en)	2016-10-25	2020-08-20	Amgen Inc.	On-body injector
CN108264547B (zh) *	2016-12-30	2021-09-21	四川科伦博泰生物医药股份有限公司	一种纯化蛋白的方法以及试剂盒
AU2018210301A1 (en)	2017-01-17	2019-08-01	Amgen Inc.	Injection devices and related methods of use and assembly
AU2018221351B2 (en)	2017-02-17	2023-02-23	Amgen Inc.	Insertion mechanism for drug delivery device
US11752258B2 (en)	2017-02-17	2023-09-12	Amgen Inc.	Drug delivery device with sterile fluid flowpath and related method of assembly
CA3050927A1 (en)	2017-03-06	2018-09-13	Brian Stonecipher	Drug delivery device with activation prevention feature
CA3052482A1 (en)	2017-03-07	2018-09-13	Amgen Inc.	Needle insertion by overpressure
IL268386B2 (en)	2017-03-09	2023-11-01	Amgen Inc	Insertion mechanism for a drug delivery device
KR20240042212A (ko)	2017-03-28	2024-04-01	암겐 인코포레이티드	플런저 로드 및 주사기 조립 시스템 및 방법
CN110709121B (zh)	2017-06-08	2022-06-24	安进公司	扭矩驱动式药物递送装置
EP3634539A1 (en)	2017-06-08	2020-04-15	Amgen Inc.	Syringe assembly for a drug delivery device and method of assembly
MX2019015472A (es)	2017-06-22	2020-02-19	Amgen Inc	Reduccion del impacto/choque de la activacion del mecanismo.
WO2018237225A1 (en)	2017-06-23	2018-12-27	Amgen Inc.	ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
ES2972207T3 (es)	2017-07-14	2024-06-11	Amgen Inc	Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
JP2020527376A (ja)	2017-07-21	2020-09-10	アムジエン・インコーポレーテツド	薬物容器のためのガス透過性シーリング部材及び組立方法
JP2020528296A (ja)	2017-07-25	2020-09-24	アムジエン・インコーポレーテツド	ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
EP3658206A1 (en)	2017-07-25	2020-06-03	Amgen Inc.	Drug delivery device with container access system and related method of assembly
WO2019032482A2 (en)	2017-08-09	2019-02-14	Amgen Inc.	HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
US11077246B2 (en)	2017-08-18	2021-08-03	Amgen Inc.	Wearable injector with sterile adhesive patch
US11103636B2 (en)	2017-08-22	2021-08-31	Amgen Inc.	Needle insertion mechanism for drug delivery device
EP3691717B1 (en)	2017-10-04	2023-02-08	Amgen Inc.	Flow adapter for drug delivery device
CN111132711B (zh)	2017-10-06	2022-07-01	安进公司	带有联锁组件的药物递送装置及相关组装方法
EP3694578A1 (en)	2017-10-09	2020-08-19	Amgen Inc.	Drug delivery device with drive assembly and related method of assembly
WO2019090079A1 (en)	2017-11-03	2019-05-09	Amgen Inc.	System and approaches for sterilizing a drug delivery device
WO2019089178A1 (en)	2017-11-06	2019-05-09	Amgen Inc.	Drug delivery device with placement and flow sensing
WO2019090303A1 (en)	2017-11-06	2019-05-09	Amgen Inc.	Fill-finish assemblies and related methods
AU2018364933B2 (en)	2017-11-10	2024-01-25	Amgen Inc.	Plungers for drug delivery devices
SG11202003004RA (en)	2017-11-16	2020-04-29	Amgen Inc	Door latch mechanism for drug delivery device
MA50903A (fr)	2017-11-16	2021-05-12	Amgen Inc	Auto-injecteur avec détection de décrochage et de point d'extrémité
US10835685B2 (en)	2018-05-30	2020-11-17	Amgen Inc.	Thermal spring release mechanism for a drug delivery device
US11083840B2 (en)	2018-06-01	2021-08-10	Amgen Inc.	Modular fluid path assemblies for drug delivery devices
EP3586860A1 (en) *	2018-06-22	2020-01-01	Universität Ulm	Complement inhibitors and uses thereof
CA3103681A1 (en)	2018-07-24	2020-01-30	Amgen Inc.	Delivery devices for administering drugs
WO2020023220A1 (en)	2018-07-24	2020-01-30	Amgen Inc.	Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
EP3826699A1 (en)	2018-07-24	2021-06-02	Amgen Inc.	Delivery devices for administering drugs
WO2020023336A1 (en)	2018-07-24	2020-01-30	Amgen Inc.	Hybrid drug delivery devices with grip portion
EP3829692A1 (en)	2018-07-31	2021-06-09	Amgen Inc.	Fluid path assembly for a drug delivery device
EP3856284A1 (en)	2018-09-24	2021-08-04	Amgen Inc.	Interventional dosing systems and methods
MA53718A (fr)	2018-09-28	2022-01-05	Amgen Inc	Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
CA3110529A1 (en)	2018-10-02	2020-04-09	Amgen Inc.	Injection systems for drug delivery with internal force transmission
MA53818A (fr)	2018-10-05	2022-01-12	Amgen Inc	Dispositif d'administration de médicament ayant un indicateur de dose
KR20210076935A (ko)	2018-10-15	2021-06-24	암젠 인크	댐핑 메커니즘을 갖는 약물 전달 장치
SG11202101824VA (en)	2018-10-15	2021-03-30	Amgen Inc	Platform assembly process for drug delivery device
BR112021007710A2 (pt)	2018-10-26	2021-08-10	Kyowa Kirin Co., Ltd.	composição farmacêutica para tratar anemia aplástica
US20220031939A1 (en)	2018-11-01	2022-02-03	Amgen Inc.	Drug delivery devices with partial drug delivery member retraction
TWI831847B (zh)	2018-11-01	2024-02-11	美商安進公司	部分針頭縮回之藥物遞送裝置及其操作方法
EP3873566A1 (en)	2018-11-01	2021-09-08	Amgen Inc.	Drug delivery devices with partial drug delivery member retraction
AU2020263289A1 (en)	2019-04-24	2021-09-16	Amgen Inc.	Syringe sterilization verification assemblies and methods
WO2021041067A2 (en)	2019-08-23	2021-03-04	Amgen Inc.	Drug delivery device with configurable needle shield engagement components and related methods
MX2023007131A (es)	2020-12-18	2023-06-27	Richter Gedeon Nyrt	Metodos para la purificacion de proteina de fusion fc-peptido replegada.
CN113402614A (zh) *	2021-04-22	2021-09-17	山东泉港药业有限公司	血小板生成素拟肽融合蛋白(fc-tmp)编码基因与应用
AU2022279223A1 (en)	2021-05-21	2023-10-19	Amgen Inc.	Method of optimizing a filling recipe for a drug container
WO2023044774A1 (en) *	2021-09-24	2023-03-30	Sichuan Clover Biopharmaceuticals, Inc.	Tpo mimetic fusion proteins and methods of use submission of sequence listing as ascii text file
TW202341992A (zh)	2022-02-02	2023-11-01	國立大學法人筑波大學	用於臍帶血移植後之血球恢復之醫藥組合物
WO2023180525A1 (en)	2022-03-24	2023-09-28	Richter Gedeon Nyrt.	Method for the manufacture of biopharmaceuticals
WO2024036324A1 (en)	2022-08-11	2024-02-15	Selecta Biosciences, Inc.	Compositions and methods related to immunoglobulin proteases and fusions thereof
CN117986346B (zh) *	2024-04-07	2024-07-26	中国人民解放军军事科学院军事医学研究院	一种tpo模拟肽及其应用

Family Cites Families (179)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2043149A1 (de) *	1969-09-01	1971-11-04	Geetainers (Europe) Ltd., St. Aubin, Jersey, Channel Isles (Großbritannien)	Deckelverschluß für Transportbehälter
US3691016A (en)	1970-04-17	1972-09-12	Monsanto Co	Process for the preparation of insoluble enzymes
CA1023287A (en)	1972-12-08	1977-12-27	Boehringer Mannheim G.M.B.H.	Process for the preparation of carrier-bound proteins
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US3941763A (en)	1975-03-28	1976-03-02	American Home Products Corporation	PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
US4002531A (en)	1976-01-22	1977-01-11	Pierce Chemical Company	Modifying enzymes with polyethylene glycol and product produced thereby
US4195128A (en)	1976-05-03	1980-03-25	Bayer Aktiengesellschaft	Polymeric carrier bound ligands
US4330440A (en)	1977-02-08	1982-05-18	Development Finance Corporation Of New Zealand	Activated matrix and method of activation
CA1093991A (en)	1977-02-17	1981-01-20	Hideo Hirohara	Enzyme immobilization with pullulan gel
US4229537A (en)	1978-02-09	1980-10-21	New York University	Preparation of trichloro-s-triazine activated supports for coupling ligands
US4289872A (en)	1979-04-06	1981-09-15	Allied Corporation	Macromolecular highly branched homogeneous compound based on lysine units
JPS6023084B2 (ja)	1979-07-11	1985-06-05	味の素株式会社	代用血液
US4640835A (en)	1981-10-30	1987-02-03	Nippon Chemiphar Company, Ltd.	Plasminogen activator derivatives
US4503235A (en)	1983-03-11	1985-03-05	Warner-Lambert Company	Process for producing 4-carbamoyl-1H-imidazolium-5-olate
US4496689A (en)	1983-12-27	1985-01-29	Miles Laboratories, Inc.	Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0154316B1 (en)	1984-03-06	1989-09-13	Takeda Chemical Industries, Ltd.	Chemically modified lymphokine and production thereof
EP0173494A3 (en)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Chimeric receptors by dna splicing and expression
EP0206448B1 (en)	1985-06-19	1990-11-14	Ajinomoto Co., Inc.	Hemoglobin combined with a poly(alkylene oxide)
US5017691A (en) *	1986-07-03	1991-05-21	Schering Corporation	Mammalian interleukin-4
US5985599A (en)	1986-05-29	1999-11-16	The Austin Research Institute	FC receptor for immunoglobulin
US4791192A (en)	1986-06-26	1988-12-13	Takeda Chemical Industries, Ltd.	Chemically modified protein with polyethyleneglycol
CH671155A5 (pt)	1986-08-18	1989-08-15	Clinical Technologies Ass
US5229490A (en)	1987-05-06	1993-07-20	The Rockefeller University	Multiple antigen peptide system
US5336603A (en)	1987-10-02	1994-08-09	Genentech, Inc.	CD4 adheson variants
ATE106249T1 (de)	1987-11-05	1994-06-15	Hybritech Inc	Polysaccharidmodifizierte immunglobuline mit reduziertem immunogenem potential oder verbesserter pharmakokinetik.
US4904584A (en)	1987-12-23	1990-02-27	Genetics Institute, Inc.	Site-specific homogeneous modification of polypeptides
EP0721983A1 (en)	1988-01-22	1996-07-17	ZymoGenetics, Inc.	Methods of producing biologically active peptide dimers
CA1340810C (en)	1988-03-31	1999-11-02	Motoo Yamasaki	Polypeptide derivatives of human granulocyte colony stimulating factor
US5223409A (en)	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
GB8824591D0 (en)	1988-10-20	1988-11-23	Royal Free Hosp School Med	Fractionation process
EP1201756A3 (en)	1988-12-22	2002-10-30	Genentech, Inc.	Method for preparing water soluble polypeptides
WO1990006952A1 (en)	1988-12-22	1990-06-28	Kirin-Amgen, Inc.	Chemically modified granulocyte colony stimulating factor
US4902502A (en)	1989-01-23	1990-02-20	Cetus Corporation	Preparation of a polymer/interleukin-2 conjugate
US5089261A (en)	1989-01-23	1992-02-18	Cetus Corporation	Preparation of a polymer/interleukin-2 conjugate
US5216131A (en)	1989-02-23	1993-06-01	Genentech, Inc.	Lymphocyte homing receptors
US5098833A (en)	1989-02-23	1992-03-24	Genentech, Inc.	DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5225538A (en)	1989-02-23	1993-07-06	Genentech, Inc.	Lymphocyte homing receptor/immunoglobulin fusion proteins
US5116964A (en)	1989-02-23	1992-05-26	Genentech, Inc.	Hybrid immunoglobulins
US5627262A (en)	1989-07-05	1997-05-06	The Board Of Regents Of The University Of Oklahoma	Method and composition for the treatment of septic shock
DK0417563T3 (da)	1989-09-12	2000-11-06	Hoffmann La Roche	TNF-bindende proteiner
US5013556A (en)	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
JPH04218000A (ja)	1990-02-13	1992-08-07	Kirin Amgen Inc	修飾ポリペプチド
US5723286A (en)	1990-06-20	1998-03-03	Affymax Technologies N.V.	Peptide library and screening systems
ES2139598T3 (es)	1990-07-10	2000-02-16	Medical Res Council	Procedimientos para la produccion de miembros de parejas de union especifica.
DE69133120T2 (de)	1990-07-17	2003-05-15	The Board Of Regents Of The University Of Oklahoma, Norman	GMP-140 Ligand
IE912365A1 (en)	1990-07-23	1992-01-29	Zeneca Ltd	Continuous release pharmaceutical compositions
US5252714A (en)	1990-11-28	1993-10-12	The University Of Alabama In Huntsville	Preparation and use of polyethylene glycol propionaldehyde
CA2082951C (en)	1991-03-15	1999-12-21	Robert M. Platz	Pulmonary administration of granulocyte colony stimulating factor
AU1674292A (en)	1991-03-15	1992-10-21	Synergen, Inc.	Pegylation of polypeptides
US5595732A (en)	1991-03-25	1997-01-21	Hoffmann-La Roche Inc.	Polyethylene-protein conjugates
US6139843A (en)	1991-04-02	2000-10-31	Albert Einstein College Of Medicine Of Yeshiva University	Peptide compositions for the treatment of HIV
US5281698A (en)	1991-07-23	1994-01-25	Cetus Oncology Corporation	Preparation of an activated polymer ester for protein conjugation
US5362852A (en)	1991-09-27	1994-11-08	Pfizer Inc.	Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
US5270170A (en)	1991-10-16	1993-12-14	Affymax Technologies N.V.	Peptide library and screening method
US5733731A (en)	1991-10-16	1998-03-31	Affymax Technologies N.V.	Peptide library and screening method
NZ244778A (en)	1991-10-21	1994-03-25	Ortho Pharma Corp	Peg imidates and protein derivatives thereof
WO1993008207A1 (en) *	1991-10-25	1993-04-29	Immunex Corporation	Novel cytokine
US5376367A (en)	1991-11-22	1994-12-27	Immunex Corporation	Fusion proteins comprising MGF and IL-3
DE69312700T2 (de)	1992-04-14	1998-02-19	Cornell Res Foundation Inc	Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
DK0615451T3 (da)	1992-05-26	2006-04-24	Immunex Corp	Hidtil ukendt cytokin der binder til CD30
US5792451A (en)	1994-03-02	1998-08-11	Emisphere Technologies, Inc.	Oral drug delivery compositions and methods
CA2142007C (en)	1992-08-11	2007-10-30	Robert Glen Urban	Immunomodulatory peptides
JPH08504320A (ja) *	1992-09-25	1996-05-14	コモンウエルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼーション	標的結合性ポリペプチド
GB9225448D0 (en)	1992-12-04	1993-01-27	Erba Carlo Spa	Improved synthesis of polymer bioactive conjugates
NZ247231A (en) *	1993-03-23	1994-10-26	Holyoake Ind Ltd	Diffuser for air conditioning system; outlet air direction thermostatically controlled
WO1995009917A1 (en)	1993-10-07	1995-04-13	The Regents Of The University Of California	Genetically engineered bispecific tetravalent antibodies
US5922545A (en)	1993-10-29	1999-07-13	Affymax Technologies N.V.	In vitro peptide and antibody display libraries
US5773569A (en)	1993-11-19	1998-06-30	Affymax Technologies N.V.	Compounds and peptides that bind to the erythropoietin receptor
US5981478A (en)	1993-11-24	1999-11-09	La Jolla Cancer Research Foundation	Integrin-binding peptides
GB2285446B (en)	1994-01-03	1999-07-28	Genentech Inc	Thrombopoietin
US5786331A (en)	1994-02-02	1998-07-28	Affymax Technologies N.V.	Peptides and compounds that bind to the IL-1 receptor
US5880096A (en)	1994-02-02	1999-03-09	Affymax Technologies N.V.	Peptides and compounds that bind to the IL-1 receptor
US5608035A (en)	1994-02-02	1997-03-04	Affymax Technologies N.V.	Peptides and compounds that bind to the IL-1 receptor
CA2183266A1 (en)	1994-02-14	1995-08-17	Richard D. Holly	Hematopoietic protein and materials and methods for making it
AU702669B2 (en) *	1994-02-14	1999-03-04	Kirin Brewery Company, Limited	Protein having TPO activity
WO1995021919A2 (en)	1994-02-14	1995-08-17	Kirin Brewery Company, Limited	Protein having tpo activity
US5795569A (en) *	1994-03-31	1998-08-18	Amgen Inc.	Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
GEP20002180B (en)	1994-03-31	2000-07-25	Amgen Inc	Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
IL111196A0 (en)	1994-10-07	1994-12-29	Yeda Res & Dev	Peptides and pharmaceutical compositions comprising them
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
AU693478B2 (en)	1994-11-10	1998-07-02	Metabolic Pharmaceuticals Limited	Treatment of obesity
IL116026A (en)	1994-11-22	2005-08-31	Rhone Poulenc Rorer Sa	Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses
JP3511321B2 (ja) *	1994-11-29	2004-03-29	出光興産株式会社	スチレン系重合体の分子量制御方法
US5641655A (en) *	1994-11-30	1997-06-24	Zymogenetics, Inc.	Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
JPH10510155A (ja)	1994-12-07	1998-10-06	バイオネブラスカ・インコーポレイテッド	組み換え融合蛋白構築物を用いるペプチドの製造方法
WO1996018412A1 (en)	1994-12-12	1996-06-20	Beth Israel Hospital Association	Chimeric cytokines and uses thereof
US5888763A (en)	1994-12-30	1999-03-30	The Rockefeller University	Peptides specific for the first Crk-SH3 domain
AU3204895A (en)	1995-02-01	1996-08-21	University Of Massachusetts Medical Center	Methods of selecting a random peptide that binds to a target protein
IL113159A0 (en)	1995-03-28	1995-06-29	Yeda Res & Dev	Synthetic peptides and pharmaceutical compositions comprising them
US6096871A (en)	1995-04-14	2000-08-01	Genentech, Inc.	Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
US5739277A (en)	1995-04-14	1998-04-14	Genentech Inc.	Altered polypeptides with increased half-life
WO1996040189A1 (en) *	1995-06-07	1996-12-19	Glaxo Group Limited	Peptides and compounds that bind to a receptor
US6251864B1 (en) *	1995-06-07	2001-06-26	Glaxo Group Limited	Peptides and compounds that bind to a receptor
EP2055712A1 (en)	1995-06-07	2009-05-06	Glaxo Group Limited	Peptides and compounds that bind to a thrombopoietin receptor
US5869451A (en) *	1995-06-07	1999-02-09	Glaxo Group Limited	Peptides and compounds that bind to a receptor
US5767078A (en)	1995-06-07	1998-06-16	Johnson; Dana L.	Agonist peptide dimers
IL118524A (en)	1995-06-19	2004-02-19	Akzo Nobel Nv	Peptides and pharmaceutical preparations containing them useful in the treatment of peptide tolerance
SI2275119T1 (sl)	1995-07-27	2013-12-31	Genentech, Inc.	Stabilna izotonična liofilizirana proteinska formulacija
US5746516A (en)	1995-08-11	1998-05-05	Hitachi Powdered Metals Co., Ltd.	Porous bearing system having internal grooves and electric motor provided with the same
WO1997008553A1 (en)	1995-08-22	1997-03-06	The Regents Of The University Of California	Targeting of proteins to the cell wall of gram-positive bacteria
US5817750A (en)	1995-08-28	1998-10-06	La Jolla Cancer Research Foundation	Structural mimics of RGD-binding sites
JPH09151200A (ja)	1995-09-29	1997-06-10	Ajinomoto Co Inc	ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤
US5670110A (en)	1995-12-21	1997-09-23	The Procter & Gamble Company	Method for making three-dimensional macroscopically-expanded webs having improved functional surfaces
US6369027B1 (en)	1995-12-22	2002-04-09	Amgen Inc.	Osteoprotegerin
CN1154971A (zh) *	1996-01-19	1997-07-23	北京医科大学	血小板生长因子(tpo)及其制备方法和用途
US5714577A (en)	1996-01-26	1998-02-03	University Of Pittsburgh	Antimicrobial peptides
SK288144B6 (sk)	1996-02-09	2013-12-02	Amgen, Inc.	Pharmaceutical composition and its use for treating inflammatory diseases
IL117223A0 (en)	1996-02-22	1996-06-18	Yeda Res & Dev	Antipathogenic polypeptides and compositions comprising them
JP4046354B2 (ja)	1996-03-18	2008-02-13	ボードオブリージェンツ，ザユニバーシティオブテキサスシステム	増大した半減期を有する免疫グロブリン様ドメイン
EP0906419A2 (en)	1996-03-28	1999-04-07	Chiron Corporation	Peptide ligands of the urokinase receptor
IL118003A0 (en)	1996-04-23	1996-08-04	Yeda Res & Dev	Novel vip fragments and pharmaceutical compositions comprising them
FR2748028B1 (fr)	1996-04-30	1998-08-14	Lab Francais Du Fractionnement	Peptides derives du facteur von willebrand et leur utilisation comme anticoagulant
US6100071A (en)	1996-05-07	2000-08-08	Genentech, Inc.	Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
AU2978697A (en)	1996-06-07	1998-01-05	Takeda Chemical Industries Ltd.	Novel peptide, process for the production of the same, and use of the same
US6126939A (en)	1996-09-03	2000-10-03	Yeda Research And Development Co. Ltd.	Anti-inflammatory dipeptide and pharmaceutical composition thereof
DE69734887T2 (de)	1996-09-10	2006-08-24	The Burnham Institute, La Jolla	Tumor findende moleküle, davon abstammende konjugate und verfahren zu deren verwendung
US5932546A (en)	1996-10-04	1999-08-03	Glaxo Wellcome Inc.	Peptides and compounds that bind to the thrombopoietin receptor
DK0934526T3 (da)	1996-10-08	2003-05-05	Bisys B V U	Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål
EP0949931B1 (en)	1996-12-06	2008-08-27	Amgen Inc.,	Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
JP4175668B2 (ja)	1996-12-20	2008-11-05	アムジエン・インコーポレーテツド	Ｏｂ融合タンパク質組成物および方法
KR19980066046A (ko)	1997-01-18	1998-10-15	정용훈	고역가의 CTLA4-Ig 융합단백질
US5955431A (en)	1997-02-05	1999-09-21	Brigham And Women's Hospital, Inc.	Mast cell protease peptide inhibitors
US5863735A (en)	1997-02-24	1999-01-26	Incyte Pharmaceuticals, Inc.	Human transmembrane 4 superfamily protein
ES2284203T5 (es)	1997-04-16	2016-03-11	Amgen Inc.	Proteínas de unión a osteoprotegerina y sus receptores
CA2286098C (en)	1997-04-17	2009-07-07	Amgen Inc.	Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
US6265535B1 (en)	1997-05-30	2001-07-24	The Trustees Of The University Of Pennsylvania	Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
JP2002504818A (ja)	1997-06-06	2002-02-12	リジェネロンファーマシューティカルズ，インコーポレイテッド	リガンドファミリーのｎｔｎ−２メンバー
WO1999005302A1 (en)	1997-07-24	1999-02-04	The Perkin-Elmer Corporation	Conjugates of transporter peptides and nucleic acid analogs, and their use
US6342220B1 (en)	1997-08-25	2002-01-29	Genentech, Inc.	Agonist antibodies
US6238667B1 (en)	1997-09-19	2001-05-29	Heinz Kohler	Method of affinity cross-linking biologically active immunogenic peptides to antibodies
WO1999018243A1 (en)	1997-10-06	1999-04-15	Millennium Pharmaceuticals, Inc.	Signal peptide containing proteins and uses therefor
KR100580333B1 (ko)	1997-10-10	2006-05-16	시토비아 인크.	디펩티드 고사 억제제 및 그의 용도
ES2173641T3 (es)	1997-11-07	2002-10-16	Conjuchem Inc	Composicion de derivados opiaceos para la fabricacion de medicamentos.
WO1999038526A1 (en)	1998-01-29	1999-08-05	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Variant peptide ligands that selectively induce apoptosis
US6162613A (en)	1998-02-18	2000-12-19	Vertex Pharmaceuticals, Inc.	Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
ATE279430T1 (de)	1998-03-05	2004-10-15	Chiron Corp	Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen
US6235872B1 (en)	1998-03-12	2001-05-22	The Burnham Institute	Proapoptotic peptides dependence polypeptides and methods of use
JP4361684B2 (ja)	1998-03-20	2009-11-11	中外製薬株式会社	エリトロポエチン受容体のためのペプチドリガンド
EP0947524A1 (en)	1998-03-30	1999-10-06	Upither B.V.	Novel peptides for the treatment of autoimmune diseases
ATE297942T1 (de)	1998-04-06	2005-07-15	Advanced Immunit Inc	Kurzes peptid zur behandlung neurodegenerativer erkrankungen
CA2330448A1 (en)	1998-04-28	1999-11-04	Applied Research Systems Ars Holding N.V.	Peg-lhrh analog conjugates
EP0972780A1 (en)	1998-05-18	2000-01-19	Applied Research Systems ARS Holding N.V.	Il-6 antagonist peptides
ES2218796T3 (es)	1998-05-21	2004-11-16	Tecnogen Scpa	Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.
ES2307337T3 (es)	1998-05-22	2008-11-16	Abbott Laboratories	Medicamentos peptidicos anti-angiogenicos.
US5932548A (en)	1998-06-03	1999-08-03	Deghenghi; Romano	Lysine containing peptides for treatment of heart disease
WO2000001402A1 (en)	1998-07-02	2000-01-13	Envision Biomedical Consulting	Antiproliferative and antiviral proteins and peptides
US6168785B1 (en)	1998-07-16	2001-01-02	Institut Pasteur	Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
US20020142374A1 (en)	1998-08-17	2002-10-03	Michael Gallo	Generation of modified molecules with increased serum half-lives
WO2000011028A2 (en)	1998-08-21	2000-03-02	Yeda Research And Development Co. Ltd.	Anti-inflammatory peptides derived from il-2 and analogues thereof
US7488590B2 (en)	1998-10-23	2009-02-10	Amgen Inc.	Modified peptides as therapeutic agents
US6660843B1 (en)	1998-10-23	2003-12-09	Amgen Inc.	Modified peptides as therapeutic agents
BRPI9914698B8 (pt)	1998-10-23	2021-05-25	Amgen Inc	composto que se liga a um receptor mp1, e , composição farmacêutica.
AU2880400A (en)	1999-02-12	2000-08-29	Amgen, Inc.	Tnf-related proteins
US6635646B1 (en)	1999-05-04	2003-10-21	Schering Corporation	Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
WO2001002440A1 (en)	1999-07-02	2001-01-11	Genentech, Inc.	Fusion peptides comprising a peptide ligand domain and a multimerization domain
US6586398B1 (en)	2000-04-07	2003-07-01	Amgen, Inc.	Chemically modified novel erythropoietin stimulating protein compositions and methods
AU2001259432B2 (en)	2000-05-03	2005-04-21	Amgen Inc.	Modified peptides, comprising an FC domain, as therapeutic agents
ATE544785T1 (de)	2000-12-05	2012-02-15	Alexion Pharma Inc	Rationell entworfene antikörper
US7396917B2 (en)	2000-12-05	2008-07-08	Alexion Pharmaceuticals, Inc.	Rationally designed antibodies
WO2002078612A2 (en)	2001-04-02	2002-10-10	Euro-Celtique S.A.	Thrombopoietin (tpo) synthebody for stimulation of platelet production
US7205275B2 (en)	2001-10-11	2007-04-17	Amgen Inc.	Methods of treatment using specific binding agents of human angiopoietin-2
US7138370B2 (en)	2001-10-11	2006-11-21	Amgen Inc.	Specific binding agents of human angiopoietin-2
US7332474B2 (en)	2001-10-11	2008-02-19	Amgen Inc.	Peptides and related compounds having thrombopoietic activity
KR20050033563A (ko)	2002-06-28	2005-04-12	센토코 인코포레이티드	포유동물 ｅｐｏ 모방 ｃｈ1 결실된 모방체, 조성물, 방법및 용도
AU2003280130B2 (en)	2002-06-28	2009-06-11	Centocor, Inc.	Mammalian CH1 deleted mimetibodies, compositions, methods and uses
US6919426B2 (en)	2002-09-19	2005-07-19	Amgen Inc.	Peptides and related molecules that modulate nerve growth factor activity
WO2004039337A2 (en)	2002-10-31	2004-05-13	Protein Design Labs, Inc.	Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
JP4959137B2 (ja)	2002-12-20	2012-06-20	アムジェンインコーポレイテッド	ミオスタチンを阻害する結合剤
PL1675606T3 (pl)	2003-08-28	2017-08-31	Janssen Pharmaceuticals, Inc.	Peptydy i związki, które wiążą się z receptorami trombopoetyny
WO2006010057A2 (en)	2004-07-08	2006-01-26	Amgen Inc.	Therapeutic peptides
ES2629397T3 (es)	2004-09-24	2017-08-09	Amgen Inc.	Moléculas de Fc modificadas
CA2600749C (en)	2005-03-10	2014-04-15	Nascacell Ip Gmbh	Dimeric or multimeric microproteins
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
AU2007208226A1 (en)	2006-01-25	2007-08-02	Amgen Inc.	Thrombopoietic compounds
JO3324B1 (ar)	2006-04-21	2019-03-13	Amgen Inc	مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
US7981425B2 (en)	2006-06-19	2011-07-19	Amgen Inc.	Thrombopoietic compounds
US8197642B2 (en) *	2007-07-26	2012-06-12	Nichiha Corporation	Inorganic board and method for manufacturing the same
US10534898B2 (en)	2017-01-18	2020-01-14	International Business Machines Corporation	Code identification

1999
- 1999-10-22 BR BRPI9914698A patent/BRPI9914698B8/pt not_active IP Right Cessation
- 1999-10-22 IL IL14202399A patent/IL142023A0/xx active Protection Beyond IP Right Term
- 1999-10-22 WO PCT/US1999/024834 patent/WO2000024770A2/en active IP Right Grant
- 1999-10-22 AU AU12239/00A patent/AU773891C/en not_active Expired
- 1999-10-22 CA CA 2346996 patent/CA2346996C/en not_active Expired - Lifetime
- 1999-10-22 AT AT99970998T patent/ATE348163T1/de active
- 1999-10-22 DK DK10011689T patent/DK2319928T3/da active
- 1999-10-22 ES ES99970998T patent/ES2279649T3/es not_active Expired - Lifetime
- 1999-10-22 SK SK496-2001A patent/SK287737B6/sk not_active IP Right Cessation
- 1999-10-22 PT PT99970998T patent/PT1124961E/pt unknown
- 1999-10-22 EP EP19990970998 patent/EP1124961B9/en not_active Expired - Lifetime
- 1999-10-22 US US09/422,838 patent/US6835809B1/en not_active Expired - Lifetime
- 1999-10-22 ME MEP-2008-421A patent/ME00238B/me unknown
- 1999-10-22 SI SI9930953T patent/SI1124961T1/sl unknown
- 1999-10-22 JP JP2000578340A patent/JP3820105B2/ja not_active Expired - Lifetime
- 1999-10-22 EP EP20060022333 patent/EP1783222B1/en not_active Expired - Lifetime
- 1999-10-22 DK DK99970998T patent/DK1124961T3/da active
- 1999-10-22 ME MEP42108 patent/MEP42108A/xx unknown
- 1999-10-22 KR KR1020017004723A patent/KR100719202B1/ko active Protection Beyond IP Right Term
- 1999-10-22 MY MYPI99004566A patent/MY126795A/en unknown
- 1999-10-22 CN CN2006100044518A patent/CN1810832B/zh not_active Expired - Lifetime
- 1999-10-22 EA EA200100465A patent/EA003998B1/ru not_active IP Right Cessation
- 1999-10-22 TW TW94140160A patent/TWI257394B/zh not_active IP Right Cessation
- 1999-10-22 ES ES10011689T patent/ES2422231T3/es not_active Expired - Lifetime
- 1999-10-22 SI SI9931072T patent/SI2319928T1/sl unknown
- 1999-10-22 CZ CZ20011287A patent/CZ302155B6/cs not_active IP Right Cessation
- 1999-10-22 CN CNB998125172A patent/CN1250721C/zh not_active Expired - Lifetime
- 1999-10-22 NZ NZ510529A patent/NZ510529A/en not_active IP Right Cessation
- 1999-10-22 DK DK06022333T patent/DK1783222T3/da active
- 1999-10-22 SI SI9931068T patent/SI1783222T1/sl unknown
- 1999-10-22 EP EP20100011689 patent/EP2319928B9/en not_active Expired - Lifetime
- 1999-10-22 DE DE200912000039 patent/DE122009000039I1/de active Pending
- 1999-10-22 HU HU0104327A patent/HU228582B1/hu unknown
- 1999-10-22 AR ARP990105333 patent/AR020934A1/es active IP Right Grant
- 1999-10-22 ES ES06022333T patent/ES2388341T3/es not_active Expired - Lifetime
- 1999-10-22 PT PT100116896T patent/PT2319928E/pt unknown
- 1999-10-22 PT PT06022333T patent/PT1783222E/pt unknown
- 1999-10-22 DE DE1999634425 patent/DE69934425T2/de not_active Expired - Lifetime
- 1999-10-22 TW TW88118317A patent/TWI250988B/zh not_active IP Right Cessation
- 1999-10-22 RS YU24301 patent/RS51237B/sr unknown
- 1999-10-22 PL PL348041A patent/PL219605B1/pl unknown
2001
- 2001-03-14 ZA ZA200102102A patent/ZA200102102B/en unknown
- 2001-04-03 BG BG11022101A patent/BG110221A/en unknown
- 2001-04-03 BG BG105401A patent/BG65663B1/bg unknown
- 2001-04-20 NO NO20011962A patent/NO331027B1/no not_active IP Right Cessation
2002
- 2002-05-27 HK HK02103927.0A patent/HK1042114B/zh not_active IP Right Cessation
2004
- 2004-09-02 US US10/933,133 patent/US8044174B2/en not_active Expired - Fee Related
2006
- 2006-01-19 US US11/335,878 patent/US9145450B2/en not_active Expired - Lifetime
- 2006-04-10 JP JP2006107321A patent/JP4332163B2/ja not_active Expired - Lifetime
- 2006-12-14 HK HK06113797A patent/HK1093075A1/xx not_active IP Right Cessation
- 2006-12-22 US US11/644,757 patent/US20070142295A1/en not_active Abandoned
2007
- 2007-03-12 CY CY20071100334T patent/CY1107526T1/el unknown
2008
- 2008-09-16 BG BG10110221A patent/BG66190B1/bg unknown
2009
- 2009-03-13 US US12/404,047 patent/US7994117B2/en not_active Expired - Fee Related
- 2009-07-29 LT LTPA2009006C patent/LTC1124961I2/lt unknown
- 2009-07-30 LU LU91598C patent/LU91598I2/fr unknown
- 2009-07-30 FR FR09C0030C patent/FR09C0030I2/fr active Active
- 2009-08-03 CY CY2009012C patent/CY2009012I2/el unknown
- 2009-08-03 NL NL300398C patent/NL300398I2/nl unknown
2011
- 2011-10-20 US US13/278,137 patent/US8748571B2/en not_active Expired - Fee Related
2012
- 2012-03-12 NO NO2012005C patent/NO2012005I2/no unknown
- 2012-04-27 US US13/458,744 patent/US8618044B2/en not_active Expired - Fee Related
- 2012-09-05 CY CY20121100797T patent/CY1113107T1/el unknown
2013
- 2013-06-14 CY CY20131100482T patent/CY1114940T1/el unknown
2014
- 2014-04-30 US US14/266,563 patent/US9534032B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1124961B9 (en)	2010-07-21
AU773891B2 (en)	2004-06-10
US20090186822A1 (en)	2009-07-23
YU24301A (sh)	2005-07-19
HK1093075A1 (en)	2007-02-23
DK1783222T3 (da)	2012-07-09
LU91598I2 (fr)	2009-09-30
CA2346996A1 (en)	2000-05-04
EA200100465A1 (ru)	2001-10-22
DK1124961T3 (da)	2007-04-10
US20120034657A1 (en)	2012-02-09
WO2000024770A9 (en)	2000-10-26
JP3820105B2 (ja)	2006-09-13
US8044174B2 (en)	2011-10-25
PL219605B1 (pl)	2015-06-30
SI1124961T1 (sl)	2007-06-30
BR9914698B1 (pt)	2014-04-29
NO2012005I2 (no)	2015-02-02
PT2319928E (pt)	2013-06-28
CZ302155B6 (cs)	2010-11-18
ES2279649T3 (es)	2007-08-16
BRPI9914698B8 (pt)	2021-05-25
RS51237B (sr)	2010-12-31
JP4332163B2 (ja)	2009-09-16
LU91598I9 (pt)	2019-01-03
KR20010099695A (ko)	2001-11-09
SI2319928T1 (sl)	2013-08-30
US9145450B2 (en)	2015-09-29
NZ510529A (en)	2003-10-31
MY126795A (en)	2006-10-31
DE122009000039I1 (de)	2009-11-05
TW200606175A (en)	2006-02-16
IL142023A0 (en)	2002-03-10
ES2422231T3 (es)	2013-09-09
EP1124961A2 (en)	2001-08-22
US20050080014A1 (en)	2005-04-14
ATE348163T1 (de)	2007-01-15
HK1042114B (zh)	2006-09-29
CN1810832A (zh)	2006-08-02
US20150024431A1 (en)	2015-01-22
TWI250988B (en)	2006-03-11
TWI257394B (en)	2006-07-01
EP1783222A1 (en)	2007-05-09
HU228582B1 (en)	2013-04-29
CA2346996C (en)	2013-11-19
EP2319928B1 (en)	2013-03-27
PT1124961E (pt)	2007-02-28
AR020934A1 (es)	2002-06-05
BG65663B1 (bg)	2009-05-29
WO2000024770A2 (en)	2000-05-04
HUP0104327A3 (en)	2003-09-29
US20070142295A1 (en)	2007-06-21
PL348041A1 (en)	2002-05-06
JP2002536960A (ja)	2002-11-05
SK4962001A3 (en)	2001-12-03
US20120208760A1 (en)	2012-08-16
CN1810832B (zh)	2012-12-12
NL300398I1 (nl)	2009-10-01
US7994117B2 (en)	2011-08-09
NO20011962D0 (no)	2001-04-20
US8748571B2 (en)	2014-06-10
LTPA2009006I1 (lt)	2022-03-10
CY1113107T1 (el)	2016-04-13
DE69934425D1 (en)	2007-01-25
NL300398I2 (nl)	2009-12-01
NO331027B1 (no)	2011-09-12
US9534032B2 (en)	2017-01-03
LTC1124961I2 (lt)	2022-03-25
EP1783222B1 (en)	2012-06-06
NO2012005I1 (no)	2012-04-02
ZA200102102B (en)	2001-11-15
CY1107526T1 (el)	2010-07-28
PT1783222E (pt)	2012-07-26
HUP0104327A2 (hu)	2002-02-28
BR9914698A (pt)	2003-01-07
BG110221A (en)	2009-06-30
CN1325447A (zh)	2001-12-05
AU773891C (en)	2005-02-17
SK287737B6 (sk)	2011-08-04
SI1783222T1 (en)	2012-09-28
MEP42108A (en)	2011-02-10
DE69934425T2 (de)	2007-09-27
EP2319928A1 (en)	2011-05-11
US6835809B1 (en)	2004-12-28
US8618044B2 (en)	2013-12-31
ME00238B (me)	2011-02-10
DK2319928T3 (da)	2013-06-24
ES2388341T3 (es)	2012-10-11
CY2009012I1 (el)	2010-07-28
HK1042114A1 (en)	2002-08-02
CN1250721C (zh)	2006-04-12
JP2006230413A (ja)	2006-09-07
NO20011962L (no)	2001-06-21
CY1114940T1 (el)	2016-12-14
WO2000024770A3 (en)	2000-09-14
AU1223900A (en)	2000-05-15
KR100719202B1 (ko)	2007-05-16
EP2319928B9 (en)	2014-04-16
BG66190B1 (bg)	2011-12-30
US20060189531A1 (en)	2006-08-24
FR09C0030I1 (fr)	2009-09-25
EP1124961B1 (en)	2006-12-13
CZ20011287A3 (cs)	2001-10-17
CY2009012I2 (el)	2010-07-28
BG105401A (en)	2003-02-28
EA003998B1 (ru)	2003-12-25

Publication	Publication Date	Title
FR09C0030I2 (fr)	2010-12-31	Composes thrombopoietiques
ATE229954T1 (de)	2003-01-15	Betacarbolinverbindungen
ID28266A (id)	2001-05-10	Senyawa-senyawa amidin
FI980732A0 (fi)	1998-03-31	Foerfarande foer koppling av dataoeverfoeringsstroemmar
FI980343A0 (fi)	1998-02-13	Foerfarande foer kontrollering av effekt
FI980783A0 (fi)	1998-04-03	Foerfarande foer utformning av en signaleringsfoerbindelse
NO20011745L (no)	2001-06-06	Forbindelser
FI980465A0 (fi)	1998-02-27	Foerfarande foer installering av tjaenster
NO20005006L (no)	2000-10-04	Kalsilytiske forbindelser
FI980327A0 (fi)	1998-02-12	Foerfarande foer foermedling av telefonsamtal
MA26681A1 (fr)	2004-12-20	Composes pyrazine
FI980150A0 (fi)	1998-01-23	Foerfarande foer oeverfoering av bildinformation
NO20006662L (no)	2000-12-27	Fluorfenylresin-forbindelser
FI980735A0 (fi)	1998-03-31	Foerfarande foer hantering av foerdroejning
FI980222A0 (fi)	1998-01-30	Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
DE59910025D1 (de)	2004-08-26	Zusatzfunktionselemente
FI980044A0 (fi)	1998-01-12	Foerfarande foer behandling av en fiberbana
FI980095A0 (fi)	1998-01-19	Foerfarande foer byggande av fartyg
DE59911430D1 (de)	2005-02-17	Zungenverbindung
FI980839A0 (fi)	1998-04-15	Framstaellning av laktid
FI980710A0 (fi)	1998-03-27	Foerfarande foer smaeltning av stenmaterial foer mineralullsproduktion
FI980443A0 (fi)	1998-02-26	Anordning foer maetning av en roerlig pappers- eller kartongbanas egenskaper
FI980146A0 (fi)	1998-01-23	Foerfarande foer roentgenavbildning av huvud- och halsomraodet
SE9800626D0 (sv)	1998-02-27	Compounds
FI3711U1 (fi)	1998-11-26	Jäykistäjä